Agenda | Abstracts |
Speakers | What is Public
Health? | Research |
Conclusions
Speakers
Howard
Abikoff, Ph.D.
Ann J. Abramowitz, Ph.D.
Thomas M. Achenbach, Ph.D.
Louis C. Danielson, Ph.D.
Laurence L. Greenhill, M.D.
Jeffrey M. Halperin, Ph.D.
Stephen P. Hinshaw, Ph.D.
Kimberly Hoagwood, Ph.D.
Peter S. Jensen, M.D.
Rachel G. Klein, Ph.D. |
Gretchen B. LeFever, Ph.D.
Christopher P. Lucas, M.D.
William E. Pelham, Jr., Ph.D.
Andrew S. Rowland, Ph.D.
Russell Schachar, M.D.
David Shaffer F.R.C.P., F.R.C.Psych.
Thomas J. Spencer, M.D.
James M. Swanson, Ph.D.
Mark L. Wolraich, M.D.
Julie M. Zito, Ph.D. |
Howard
Abikoff, Ph.D.
NYU Medical Center
550 First Avenue
New York, NY 10016
Dr.
Abikoff is Professor of Clinical Psychiatry at New York University Medical
Center and Director of Research at the NYU Child Study Center. Dr.
Abikoff’s clinical research activities have spanned three interrelated
areas: the development of novel treatment approaches, treatment evaluation
and the development of measures to quantify treatment outcome. Much of his
work has been funded by the National Institute of Mental Health, and has
centered on treatment development and treatment evaluation of children with
Attention Deficit Hyperactivity Disorder, as well as on youngsters with
Conduct Disorder. These large clinical trials have compared the efficacy of
pharmacological and psychosocial treatments, alone and in combination. More
recently, as funded investigator of one of the NIMH supported Research Units
in Pediatric Psychopharmacology (RUPP), Dr. Abikoff’s focused his research
on the clinical efficacy of psychopharmacological compounds for youth with
anxiety disorders. Dr. Abikoff has served as a reviewer on numerous NIMH
panels and study sections, and recently participated as a member of the
National Advisory Mental Health Council Clinical and Services Research
Workgroup. He currently serves on the editorial boards of four peer reviewed
journals, and has participated as an ad hoc reviewer on more than a dozen
other psychology, psychiatry and educational journals.
Return
to Top
Ann
J. Abramowitz, Ph.D.
Dr.
Abramowitz is a graduate of the University of Rochester in Psychology. In
California, she taught children with autism for three years. She obtained a
Masters degree in Learning Disabilities and Behavior Disorders from the
University of Oregon, and taught special education students in California
before moving to Williamsburg, VA. There, she coordinated the school
district's noncategorical preschool handicapped program and early
identification efforts. She then was Coordinator of Special Education. She
obtained her Ph.D. in Clinical Psychology from the State University of New
York at Stony Brook in 1988, serving her clinical internship at the Emory
University School of Medicine. Currently, she is Associate Professor of
Psychiatry and Behavioral Sciences at Emory University School of Medicine,
where she is Director of the Center for Learning and Attention Deficit
Disorders. In this capacity, she and her staff evaluate children and
adolescents with learning, behavioral, and/or attentional problems, and
provide treatment that includes behavioral family therapy, individual
behavior therapy, and school consultations. She is a co-investigator on the
NIMH multi-site study of multimodal treatment of ADHD (Columbia/Mt. Sinai
site), and collaborates on research investigating the genetic bases of ADHD.
She
consults with the Centers for Disease Control and Prevention on the current
project involving public health issues and ADHD.
Return
to Top
Thomas M. Achenbach,
Ph.D.
Department of
Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT 05401-3456
Thomas M. Achenbach,
Professor of Psychiatry and Psychology, is Director of the Center for
Children, Youth, and Families at the University of Vermont Department of
Psychiatry. A summa cum laude graduate of Yale, he received his Ph.D. from
the University of Minnesota and was a Post-doctoral Fellow at the Yale Child
Study Center. Before moving to the University of Vermont, Dr. Achenbach
taught at Yale and was a Research Psychologist at the National Institute of
Mental Health. He has been a DAAD Fellow at the University of Heidelberg,
Germany; an SSRC Senior Faculty Fellow at Jean Piaget’s Centre
d’Epistemologie Genetique in Geneva; Chair of the American Psychological
Association’s Task Force on Classification of Children’s Behavior; and a
member of the American Psychiatric Association’s Advisory Committee on
DSM-III-R. He has authored over 150 publications, including Developmental
Psychopathology; Research in Developmental Psychology: Concepts,
Strategies, Methods; Assessment and Taxonomy of Child and Adolescent
Psychopathology; Empirically Based Taxonomy; Empirically Based
Assessment of Child and Adolescent Psychopathology (with Stephanie H.
McConaughy); and Manuals for the Child Behavior Checklist, Teacher’s
Report Form, Youth Self-Report, and other standardized assessment
instruments. Dr. Achenbach’s honors include the Distinguished Contribution
Award of the American Psychological Association’s Section on Clinical
Child Psychology and the University Scholar Award of the University of
Vermont.
Return
to Top
Louis C. Danielson,
Ph.D.
Department of
Education
Office of Special Education, Room 3553
Switzer Building
331 C Street, SW
Washington, DC 20202
Louis Danielson, a
national leader in the field of special education, has been involved in
programs that improve results for students with disabilities for nearly
three decades. He brings an unparalleled depth of knowledge in both special
education policy and research to his current position as Director of the
Research to Practice Division in the Office of Special Education Programs (OSEP)
at the U.S. Department of Education. Dr. Danielson was awarded a Ph.D. in
educational psychology from Pennsylvania State University in 1976. During
his career, he has served many roles in the field of education, including
secondary school science and mathematics teacher, school psychologist, and
teacher at the university level. For the past twenty-three years, Dr.
Danielson has held leadership roles in OSEP and is currently responsible for
the discretionary grants program, including research, technical assistance
and dissemination, personnel preparation, technology, and parent training
priorities, national evaluation activities, and other major policy-related
studies in OSEP. He has served in numerous research and policy roles across
the Department and has represented OSEP in major school reform activities. A
frequent contributor to professional journals, Dr. Danielson has published
extensively in the literature and is a frequent speaker at national and
international conferences and events focusing on special education. His
particular areas of interest include policy implementation and national
evaluation studies.
Return
to Top
Laurence L. Greenhill,
M.D.
New York State
Psychiatric Institute
1051 Riverside Drive, Room 2302
New York City, NY 10032
Dr. Greenhill is a
professor of Clinical Psychiatry at Columbia University and Medical Director
of the Disruptive Behavior Disorders Clinic at Columbia Presbyterian Medical
Center. Dr. Greenhill is a internationally recognized expert in
psychopharmacology and, in particular, such treatments for ADHD. He has
conducted research on efficacy of sustained release methylphenidate
preparations, familial pathways in offspring of adult suicide attempters,
effects of age on the cardiovascular responses to tricyclic antidepressants,
and the efficacy of multimodal treatments in children with ADHD. He is the
principal investigator of three NIMH grants, including the New York State
Psychiatric Institute site of the Multimodal Treatment Study of Attention
Deficit Hyperactivity Disorder (MTA Study). He currently holds several
pharmaceutical company contracts to investigate efficacy and safety of a
variety of psychopharmacological interventions. Dr. Greenhill is the author
of over 50 published articles and has edited three books, including a
monograph on methylphenidate. He serves as the current Chair of the Steering
Committee of the MTA Study and coordinated the development of its medication
manual. He has completed a five-year term as a member of the Workgroup on
Research of the Academy of Child and Adolescent Psychiatry, sits on the
Scientific Advisory Board to the University of Pittsburgh Adolescent
Alcoholism Research Center, and is a member of the NIMH Data Safety and
Monitoring Board.
Return
to Top
Jeffrey M. Halperin,
Ph.D.
Department of
Psychology
Queens College
65-30 Kissena Boulevard
Flushing, NY 11367
Dr. Halperin is a
Professor of Psychology at Queens College and the Graduate School and
University Center of the City University of New York (CUNY), and Head of the
Neuropsychology Doctoral Subprogram of CUNY. In addition, he is a
Professorial Lecturer in the Department of Psychiatry at the Mount Sinai
School of Medicine. Dr. Halperin received his Ph.D. in Psychology from CUNY
in 1979, and completed a Post-doctoral Fellowship in Psychopharmacology at
Schering - Plough Pharmaceutical Corporation in 1980. For nearly two decades
Dr. Halperin has been conducting research on diagnostic and treatment
issues, as well as neural functioning, in children with ADHD. A primary
focus of his research has been to develop objective measures to evaluate
symptomatology in children with ADHD and to use these measures to identify
more homogeneous subgroups of children with the disorder. In addition,
through the use of neuropsychological and neurochemical measures, he has
examined the ways in which neural substrates might differ in subgroups of
children with ADHD as a function of comorbidity and learning disabilities.
Return
to Top
Stephen P. Hinshaw,
Ph.D.
Department of
Psychology #1650
University of California at Berkeley
3210 Tolman Hall
Berkeley, CA 94720-1650
Stephen Hinshaw is
Professor of Psychology and Director of Clinical Psychology Training at the
University of California, Berkeley. He received his A.B. from Harvard in
1974, and he subsequently directed day school and residential programs for
children with developmental disabilities in New England. He received his
Ph.D. in Clinical Psychology from UCLA in 1983. He was a clinical psychology
intern at UCLA's Neuropsychiatric Institute from 1981-2 and a post-doctoral
fellow at the Langley Porter Psychiatric Institute of the University of
California, San Francisco, from 1983-5. He taught in the Psychology
Department at UCLA from 1986-1990 and joined the Berkeley faculty in 1990.
His work focuses on developmental psychopathology, with particular emphasis
on (a) peer and family relationships in children with externalizing
disorders, (b) neuropsychological risk factors for and correlates of
psychopathology, (c) comparisons and combinations of pharmacologic and
psychological interventions for children with ADHD, (d) assessment and
evaluation, and (e) conceptual and definitional issues in the field. He has
authored over 90 articles and chapters on child psychopathology; his book, Attention
Deficits and Hyperactivity in Children, was published by Sage
Publications in 1994. He is on the editorial board of several leading
journals in the field and is currently President of the International
Society for Research in Child and Adolescent Psychopathology.
Return
to Top
Kimberly Hoagwood,
Ph.D.
Dr. Hoagwood is
Associate Director of Child and Adolescent Mental Health Research at the
National Institute of Mental Health. She also holds the positions of Chief
of Child Mental Health Services Research and Chief of Treatment and Service
Effectiveness Research. Prior to her appointment at NIMH, Dr. Hoagwood was
Research Director at the Texas Education Agency, where she supervised a
state-wide, cross-agency program of evaluation on school-based services for
children with serious mental disorders. Dr. Hoagwood earned her doctorate in
School Psychology, and practiced clinically for nine years. She has held
academic appointments at the Pennsylvania State University and the
University of Maryland. Among her numerous publications are articles
examining clinical and service effectiveness in children’s services,
trends in psychotropic medication practices, treatment services for ADHD,
and genetic epistemology in the work of Gabriel Garcia-Márquez.
Return
to Top
Peter S. Jensen,
M.D.
Center for the
Implementation of Science in Child Mental Health
Division of Child and Adolescent Psychiatry
New York State Psychiatric Institute
Columbia University
New York, NY 10032
Dr. Jensen is the
Associate Director of Child and Adolescent Research at the National
Institute of Mental Health (NIMH), currently on special assignment to the
Division of Child & Adolescent Psychiatry, Columbia University. Formerly
with the Walter Reed Army Institute of Research, Dr. Jensen joined NIMH in
1989. Dr. Jensen is the lead NIMH investigator on the six-site NIMH and
Department of Education-funded study of Multimodal Treatment of ADHD (the MTA
Study), and is also an investigator on other NIMH multi-site studies.
Dr. Jensen serves on a number of editorial and scientific advisory boards
(including the CH.A.D.D. Professional Advisory Board and the Tourettes
Syndrome Association Scientific Board), is the author of over 100 scientific
articles and chapters, and has edited two books on children's mental health
research. For his research, writing, and teaching, he has received many
national awards, including the Norbert Reiger Award from the American
Academy of Child and Adolescent Psychiatry (twice, 1990 and 1996), the Agnes
Purcell McGavin Award (1996) and the Blanche Ittelson Award (1998) from the
American Psychiatric Association, Special Recognition Awards from the
American Psychological Association and the Association for Child Psychiatric
Nursing, and most recently, the Exemplary Psychiatrist Award from the
National Alliance for the Mentally Ill. He and Susi Myers Jensen (from Palo
Alto) have 5 children, aged 14 to 23.
Return
to Top
Rachel G. Klein,
Ph.D.
New York State
Psychiatric Institute
Unit #80
722 West 168th Street
New York, NY 10032
Dr. Rachel Klein is
Professor of Clinical Psychology (in Psychiatry) at Columbia University,
College of Physicians and Surgeons, and Director of Clinical Psychology, New
York State Psychiatric Institute and Columbia Presbyterian Medical Center.
She has been an active investigator of childhood psychopathology for over
three decades. She has been the recipient of numerous grant awards from the
NIMH to investigate the treatment, as well as the natural history, of
childhood and adolescent psychopathology. She has conducted major controlled
treatment studies of the clinical efficacy of psychotherapeutic, as well as
psychopharmacologic, interventions in children and adolescents. Her
therapeutics research has spanned a broad spectrum of psychopathology,
attention deficit hyperactivity disorder, conduct disorder, learning
disorders, anxiety disorders, and major depression. Her interest in
developmental psychopathology has led to longitudinal studies of children
and adolescents with separation anxiety disorder, with attention deficit
hyperactivity disorder, and with learning disorders. Her more recent related
activities focus on risk factors for the development of psychiatric
disorders in young children. Dr. Klein has published numerous scientific
papers in child psychopathology. She has played a major role in the
mentoring of junior researchers who have gone on to become well-known
independent investigators.
Return
to Top
Gretchen B. LeFever,
Ph.D.
Center for Pediatric
Research, CHKD/EVMS
855 West Brambleton Avenue
Norfolk, VA 23510-1001
Dr. LeFever is a
practicing clinical psychologist and Founding Director of the School Health
Initiative for Education (SHINE), a coalition in eastern Virginia comprised
of school districts, health care providers, and others dedicated to
improving the mental health and physical health of school children. She is
also an Assistant Professor of Pediatrics at the Eastern Virginia Medical
School in the Center for Pediatric Research. Dr. LeFever has presented and
published a number of papers on the epidemiology, diagnosis, and management
of attention deficit hyperactivity disorder (ADHD), and is a nationally
recognized expert in child behavioral and developmental disorders.
Return
to Top
Christopher P. Lucas,
M.D.
New York State
Psychiatric Institute
Unit #78
722 West 168th Street
New York, NY 10032
Dr. Lucas obtained
his medical and psychiatric training at the University of Leeds, UK. Whilst
in England he computerized an Audio CASI version of the NIMH DISC 2.1 using
interactive-video / laser-disc technology. He joined the department of Child
Psychiatry at Columbia University in 1993 as an NIMH Research Fellow and
worked with Dr. David Shaffer on a suicide-screening project in a high
school population. He obtained a Scientist Development Award for Clinicians
from NIMH (K-20) in 1995 to study the measurement of child psychopathology.
This grant comprises a series of projects studying the development of a
general purpose diagnostic screening instrument (The DISC Predictive Scales
– DPS), the computerization of a self-completion (Audio CASI) version of
the NIMH Diagnostic Interview Schedule for Children – The Voice DISC
computer, together with other experimental studies of the reliability and
validity of diagnostic assessments. For the past five years, he has directed
a team of programmers and research assistants devising and testing
computerized versions of the NIMH-DISC. More recently the Columbia DISC
Development Group (of which he is the Research Director) has been developing
a general purpose authoring system (JADE) which will allow non-programmers
to computerize complex interview batteries (incorporating audio-CASI and
multilingual capabilities). Dr. Lucas’ current research interests include
testing the DSM-IV version of the DISC Predictive Scales (DPS-4) in a large
representative population-based sample, experimental studies of the
reliability and validity of Audio-CASI versions of the DPS-4 and DISC, as
well as adapting the DISC for use by the parents of pre-school children (the
Young Child DISC).
Return
to Top
William E. Pelham,
Jr., Ph.D.
Department of
Psychology
Park Hall
SUNY Buffalo
Buffalo, NY 14260
Dr. Pelham is a
graduate of Dartmouth College and earned his Ph.D. in Clinical Psychology
from the State University of New York at Stony Brook in 1976. He was been a
faculty member in psychology department clinical training programs
(Washington State University, Florida State University) from 1976 until
1986. From 1986 until 1996, he was the Director of the ADHD Clinic and
Research Program and Professor of Psychiatry at Western Psychiatric
Institute and Clinic, the University of Pittsburgh School of Medicine (WPIC),
and he maintains a laboratory at WPIC as an adjunct Professor of Psychiatry.
He is currently Professor of Psychology, Director of the ADHD Program, and
Director of Clinical Training at the State University of New York at
Buffalo. His summer treatment program for ADHD children has been recognized
by the American Psychological Association (APA) as a Model Service Delivery
program in Child and Family Mental Health (Roberts, 1996) and is widely
recognized as the state of the art in treatment for ADHD. Dr. Pelham has
authored or co-authored more than 125 professional papers and given more
than 250 presentations dealing with ADHD and its treatment, both
psychosocial and pharmacological. Dr. Pelham is a fellow of the American
Psychological Association and the American Psychological Society, President
of the Section on Child Clinical Psychology of Div. 12 of the APA, Past
President of the International Society for Research in Child and Adolescent
Psychopathology, and Past-President of the Professional Group for Attention
Deficit and Related Disorders. He has held more than 20 research grants from
federal agencies, foundations, and pharmaceutical companies, and is
currently a Principal Investigator on multiple federal and industrial
grants. He has served as a consultant/advisor on ADHD and related topics to
several federal agencies, including NIMH, NIAAA, NIDA, IOM, OMAR, and the
CDC.
Return
to Top
Andrew S. Rowland,
Ph.D.
NIEHS
P.O. Box 12233
Research Triangle Park, NC 27709-2233
Dr. Rowland
received his undergraduate degree in "Health and Society" from the
University of Pennsylvania, a Master’s degree in sociology from the
University of California, Santa Cruz and a Doctoral degree in Epidemiology
from the University of North Carolina, Chapel Hill. Dr. Rowland was trained
as a reproductive and environmental epidemiologist and his dissertation was
about the effects of occupational nitrous oxide exposure on the fertility of
female dental assistants. In 1990, Dr. Rowland received the Greenberg
dissertation award for the best dissertation at the UNC School of Public
Health, as well as the Abraham Lililienfeld award from the Society for
Epidemiologic Research for the best student paper based on a dissertation.
Since that time, Dr. Rowland has been working as an epidemiologist at the
National Institute of Environmental Health Sciences where his work has
focused on the reproductive effects of heavy metals and pesticides. He
became interested in the possible effects of environmental exposures during
pregnancy on childhood development, which lead to his current research on
ADHD. He is prinicipal investigator of a study of the prevalence of and risk
factors for ADHD in a North Carolina County. Dr. Rowland is also an active
member of the steering committee of a coalition of professionals and social
service agencies who are working together to provide extra services to the
children identified with ADHD by the epidemiologic study.
Return
to Top
Russell Schachar,
M.D.
Psychiatry Research
The Hospital for Sick Children
555 University Avenue
Toronto, Ontario M5G 1X8 Canada
Dr. Schachar was
trained in medicine at the University of Toronto (graduated 1971) and
completed his Fellowship in Psychiatry in the Department of Psychiatry at
McMaster University (graduated 1975). Fellowship funding from the Ontario
Mental Health Foundation and the Medical Research Council of Canada
supported further training in research into child psychiatric disorders at
the Institute of Psychiatry, University of London, London, England, under
the supervision of Professor Sir Michael Rutter. Dr. Schachar's fellowship
research involved studies of the epidemiology of Attention Deficit
Hyperactivity Disorder (ADHD), effects of methylphenidate in ADHD, and the
reliability of commonly used behaviour rating scales. Following this
training, Dr. Schachar assumed a position in the Department of Psychiatry,
the Hospital for Sick Children. After a period of five years, during which
Dr. Schachar was director of the Outpatient Department of Psychiatry, he
became the Director of Child Psychiatry Research within the Hospital and the
Research Institute, as well as of the Division of Child Psychiatry within
the Department of Psychiatry at the University of Toronto.
Currently, he is a
Professor in the Faculty of Medicine, a Member of the Institute of Medical
Science and a member of the post graduate faculty, Faculty of Education,
University of Toronto. Dr. Schachar has been a Senior Research Fellow of the
Ontario Mental Health Foundation and was the recipient in 1995 of the Elaine
Schlosser Lewis Award from the American Academy of Child & Adolescent
Psychiatry for his research on ADHD. Current research interests include
cognition and psychopathology, genetics of ADHD, and treatment studies of
disruptive behavior disorders.
Return
to Top
David Shaffer
F.R.C.P., F.R.C.Psych.
New York State
Psychiatric Institute
723 West 168th Street
New York, NY 10032
Dr. Shaffer is an
Irving Philips Professor of Child Psychiatry at the College of Physicians
& Surgeons at Columbia University in New York City, and Chief of the
Division of Child Psychiatry at Columbia Presbyterrian Medical Center and
New York State Psychiatric Institute. His principal research interests
are in the measurement and classification of child psychiatric disorders and
in the epidemiology and prevention of adolescent suicide. He co-chaired the
DSM IV Child & Adolescent disorders work group and currently leads the
child work group of the APA’s Committee on Diagnosis and Asessment. He is
President of the American Foundation for Suicide Prevention and
Past-President of the Society for Research in Child & Adolescent
Psychopathology.
Dr. Shaffer has
undertaken epidemiological studies on suicide and has assisted in the
development of instruments for epidemiological purposes. His early research
was on the relationship between Attention Deficit Hyperactivity Disorder and
neurological disorder. He has written a number of papers on problems raised
by the non-specificity of inattention and hyperactivity and on the
difficulties in establishing a retrospective diagnosis of ADHD in adults. He
received the American Suicide Foundation’s award for research in suicide
in 1989, the American Mental Health Fund Research Award in 1990, and the
American Psychiatric Association's McGavin Award in 1995. He was chosen to
be a founding member of the Academy of Medical Sciences in London in1998.
Return
to Top
Thomas J. Spencer,
M.D.
Massachusetts General
Hospital
Child Psychiatry WACC 625
Boston, MA 02114
Dr. Spencer is an
Associate Professor of Psychiatry at Harvard Medical School and the
Assistant Chief of the Pediatric Psychopharmacology Research Program at
Massachusetts General Hospital. His research and clinical interests have
focused on the effectiveness and safety of standard and novel pharmacologic
treatments of Attention-Deficit/Hyperactivity Disorder (ADHD) throughout the
lifecycle. In addition, Dr. Spencer’s research has focused on the
characterization and treatment of Tic Disorders. He has received research
funding from the Tourette Society and the National Institute of Mental
Health (NIMH), and has published over 70 scientific articles and written 30
book chapters.
Before joining
Massachusetts General Hospital, Dr. Spencer was the Head of the Clinical
Team, Child and Adolescent Division, of the Massachusetts Department of
Mental Health. He became a co-investigator in Dr. Biederman’s longitudinal
and family-genetic studies of ADHD.
Dr. Spencer
recently received an NIMH FIRST Award supporting a study of medium-term
(six-month) stimulant treatment in adults with ADHD. This investigation will
document the translation of improvement in ADHD symptoms into increased
functional capacities and quality of life.
Return
to Top
James M. Swanson,
Ph.D.
Child Development
Center
University of California, Irvine
19722 MacArthur
Irvine, CA 92612
Dr. Swanson
received his doctorate from Ohio State Unviersity and is a Professor of
Pediatrics and Cognitive Sciences at the University of California, Irvine.
At the University of California, Irvine, Dr. Swanson founded the Child
Development Center (UCI-CDC), which has speciality programs for ADHD
children. The UCI-CDC school programs include a school-based day treatment
program and a paraprofessional program for delivering school-based
interventions for ADHD students in regular classrooms in the public schools.
The UCI-CDC research program includes investigations of multimodality
treatment of ADHD children, investigations of the neurobiology of ADHD, and
pharmacological investigations of new medications for ADHD. Over the past 20
years, his work with ADHD children has been supported by the Ontario mental
Health Foundation, the MacArthur Foundation, The Irvine Community
Foundation, the Educational Foundation of America, the Sackler Foundation,
the U.S. Department of Education, the National Institute of Mental Health,
and the National Institute on Child Health and Development.
Return
to Top
Mark L. Wolraich,
M.D.
Child Development
Center
Vanderbilt University
2100 Pierce Avenue, MCS Room 405
Nashville, TN 37232-3573
Dr. Wolraich is a
Professor of Pediatrics and the Director of the Division of Child
Development in the Department of Pediatrics at Vanderbilt University in
Nashville, Tennessee. He received his medical degree from the State
University of New York Upstate Medical Center in Syracuse, New York. Since
his appointment at Vanderbilt, Dr. Wolraich has assumed several leadership
positions to include his current directorships of the Child Development
Center (since 1990) and the Junior League Center for Chronic Illnesses and
Disabilities in Children. His research interests include ADHD, diet and
behavior relationships, professional expectations and prognostications
towards developmentally disabled children, and communication between
physicians and patients or parents. Dr. Wolraich was the recipient of the
Society of Pediatric Psychology’s 1999 Lee Salk Distinguished Service
Award. His current research efforts include A NIMH funded research into ways
pediatricians and schools can to enhance ADHD treatment effectiveness and a
Maternal and Child Health Bureau funded study of rural leadership education
about individuals with neurodevelopmental and related disorders and their
families in Tennessee.
Return
to Top
Julie M. Zito,
Ph.D.
Pharmacy Practice and
Science
Center for Drugs and Public Policy
101 North Greene Street, 5th Floor
Baltimore, MD 21201
Dr. Zito is an
Associate Professor of Pharmacy and Medicine at the University of Maryland,
Baltimore. For the past 15 years, Dr. Zito has specialized in the
pharmacoepidemiology of psychiatric disorders and analyses of patterns of
psychotropic medication for the treatment of mental disorders, using data
from usual practice settings (psychiatric inpatients, Medicaid and HMO
populations). She has over 50 publications covering such varied topics such
as adult schizophrenia, [Patient Outcomes Research Team (PORT)] and
psychotropic medication treatment patterns for children and adolescents. She
authored a 1994 text, Psychotherapeutic Drug Manual and has authored
several book chapters on applying pharmacoepidemiologic methods to the
evaluation of drug therapy of adult mental disorders and child
psychiatric/behavioral disorders.
Dr. Zito is an
editorial board member of Medical Care and the Journal of Child
and Adolescent Psychopharmacology. She is active in the American Public
Health Association Medical Care section where she will be Section Chair for
the next two years. She teaches a graduate course in Pharmacoepidemiology.
Advocacy issues include direct-to-consumer prescription drug advertising,
FDA drug evaluation, and access to health care for the poor.
[Return
to Top]